PRIN 2022 FINANZIATI DIMI

CODICE 
PROGETTO
RESPONSABILEDIP.RUOLOCOORDINATORE NAZIONALETITOLO PROGETTO
2022FFX5SZ CANEPA MarcoDIMIPICANEPA Marco
Università degli Studi di GENOVA
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY) 
2022ZH5CRB DEL MASTRO LuciaDIMIPIDEL MASTRO Lucia
Università degli Studi di GENOVA
Genomic, immune, and clinical characterization of estrogen receptor-positive, HER2-low breast cancer to improve treatment personalization in early breast cancer patients: a translational, multicenter trial
2022HTYFEL FERONE DiegoDIMIPIFERONE Diego
Università degli Studi di GENOVA
Epigenomic and Transcriptomic landscape of GH-secreting pituitary adenomas in a “paradoxical” background 
20228Z8C95 FILACI GilbertoDIMIRESP UOCORSICO Angelo Guido
Università degli Studi di PAVIA 
MesenchymAl stem cell fReeze-dried secreTome for lUng fibROsis therapy: 
efficacy proof-of-concept in a murine model (ARTURO)
20222MTTNXGHIORZO PAOLADIMIRESP UOGRAMMATICO Paola
Università degli Studi di ROMA "La Sapienza" 
Deciphering the genetic background of cutaneous melanoma: inquiring into 
gene-specific oncophenotypes and non-invasive biomarkers of prognosis and therapy response
2022X2JTPFLAMBERTINI MatteoDIMIRESP UOTOSS Angela
Università degli Studi di MODENA e REGGIO EMILIA
PROGNOSTIC AND PREDICTIVE ROLE OF INTRINSIC MOLECULAR SUBTYPES IN 
BRCA-ASSOCIATED BREAST CANCER (THE PAMBRACA STUDY)
20227SWSBR MONACELLI FiammettaDIMIRESP UOMECOCCI Patrizia
Università degli Studi di PERUGIA 
Senotherapeutics to prevent cognitive decline: a randomized clinical trial of 
metformin in subjects with mild cognitive impairment.
20223XM78Z ZOPPOLI GABRIELEDIMIPIZOPPOLI Gabriele
Università degli Studi di GENOVA
Development of novel integrated tools for non-invasive differential diagnosis of early breast cancer through the analysis of peripheral blood samples 
Ultimo aggiornamento